C
ELV icon

CFO4Life’s Elevance Health ELV Stock Holding History

CFO4Life’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$687K Buy
+1,340
New +$680K 0.15% 81

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

CFO4Life's ELV Position: Q4 2022 in Review

CFO4Life opened a new position in Elevance Health (ELV) in Q4 2022: 1,340 shares worth $687K. The stake represents 0.15% of the portfolio and ranks #81 among its holdings.

1,549 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

  • CFO4Life held 1,340 shares of Elevance Health worth $687K as of Q4 2022.
  • Elevance Health was a new CFO4Life position in Q4 2022.
  • Elevance Health made up 0.15% of CFO4Life's portfolio in Q4 2022, its #81 holding.
  • 1,549 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on CFO4Life's 13F filing for Q4 2022, filed 11 Jan 2023.